IL71904A - Substituted(spiro imidazolidine-4,3-indoline)-2,2,5-triones - Google Patents

Substituted(spiro imidazolidine-4,3-indoline)-2,2,5-triones

Info

Publication number
IL71904A
IL71904A IL71904A IL7190484A IL71904A IL 71904 A IL71904 A IL 71904A IL 71904 A IL71904 A IL 71904A IL 7190484 A IL7190484 A IL 7190484A IL 71904 A IL71904 A IL 71904A
Authority
IL
Israel
Prior art keywords
spiro
imidazolidine
trione
indoline
triones
Prior art date
Application number
IL71904A
Other languages
English (en)
Other versions
IL71904A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL71904A0 publication Critical patent/IL71904A0/xx
Priority to IL82822A priority Critical patent/IL82822A0/xx
Publication of IL71904A publication Critical patent/IL71904A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL71904A 1983-05-25 1984-05-23 Substituted(spiro imidazolidine-4,3-indoline)-2,2,5-triones IL71904A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL82822A IL82822A0 (en) 1983-05-25 1987-06-09 Imidazolidinedione derivatives and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/497,962 US4464380A (en) 1983-05-25 1983-05-25 Imidazolidinedione derivatives

Publications (2)

Publication Number Publication Date
IL71904A0 IL71904A0 (en) 1984-09-30
IL71904A true IL71904A (en) 1988-01-31

Family

ID=23979057

Family Applications (1)

Application Number Title Priority Date Filing Date
IL71904A IL71904A (en) 1983-05-25 1984-05-23 Substituted(spiro imidazolidine-4,3-indoline)-2,2,5-triones

Country Status (19)

Country Link
US (1) US4464380A (de)
EP (1) EP0127412B1 (de)
JP (1) JPS604183A (de)
KR (1) KR860001869B1 (de)
AT (1) ATE57531T1 (de)
AU (1) AU543916B2 (de)
CA (1) CA1266270A (de)
DE (1) DE3483402D1 (de)
DK (1) DK163924C (de)
ES (2) ES532736A0 (de)
FI (1) FI78699C (de)
GR (1) GR82020B (de)
HU (1) HU190548B (de)
IE (1) IE57520B1 (de)
IL (1) IL71904A (de)
PH (1) PH21151A (de)
PL (3) PL143070B1 (de)
PT (1) PT78625A (de)
YU (2) YU43931B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE37371T1 (de) * 1984-08-20 1988-10-15 Pfizer Verfahren zur herstellung asymmetrischer hydantoine.
US4762839A (en) * 1985-06-06 1988-08-09 Tanabe Seiyaku Co., Ltd. Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
ATE229948T1 (de) * 1995-10-18 2003-01-15 Hoffmann La Roche Hydroxymethylierung von tocopherolen
WO2000037470A1 (en) 1998-12-19 2000-06-29 Janssen Pharmaceutica N.V. Antihistaminic spiro compounds
EP2013216A2 (de) * 2006-02-07 2009-01-14 AstraZeneca AB Neue spiro[imidazolidin-4,3'-indol]-2,2',5'(1h)-trione zur behandlung von mit dem vanilloidrezeptor 1 assoziierten leiden

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
ZA806623B (en) * 1979-11-13 1981-12-30 Ici Ltd Substituted indoline-2-one derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
IE52879B1 (en) * 1981-05-12 1988-03-30 Ici Plc Pharmaceutical spiro-hydantoin derivatives

Also Published As

Publication number Publication date
KR860001869B1 (ko) 1986-10-24
EP0127412A3 (en) 1987-09-02
JPH0573754B2 (de) 1993-10-15
PL143290B1 (en) 1988-02-29
FI78699C (fi) 1989-09-11
GR82020B (de) 1984-12-12
FI842079A (fi) 1984-11-26
ES8607304A1 (es) 1986-06-01
ES540858A0 (es) 1986-06-01
YU43958B (en) 1989-12-31
PH21151A (en) 1987-07-30
PL143070B1 (en) 1988-01-30
ES8600764A1 (es) 1985-10-16
HUT34194A (en) 1985-02-28
AU543916B2 (en) 1985-05-09
DE3483402D1 (de) 1990-11-22
CA1266270A (en) 1990-02-27
IE57520B1 (en) 1993-05-19
IE841294L (en) 1984-11-25
DK250084D0 (da) 1984-05-22
PL247804A1 (en) 1985-08-13
JPS604183A (ja) 1985-01-10
DK250084A (da) 1984-11-26
DK163924B (da) 1992-04-21
ES532736A0 (es) 1985-10-16
US4464380A (en) 1984-08-07
ATE57531T1 (de) 1990-11-15
EP0127412B1 (de) 1990-10-17
IL71904A0 (en) 1984-09-30
FI842079A0 (fi) 1984-05-24
YU212286A (en) 1987-10-31
YU89784A (en) 1987-04-30
KR840009101A (ko) 1984-12-24
YU43931B (en) 1989-12-31
PT78625A (en) 1984-06-01
DK163924C (da) 1992-09-14
AU2856384A (en) 1984-11-29
FI78699B (fi) 1989-05-31
PL252850A1 (en) 1985-11-19
EP0127412A2 (de) 1984-12-05
HU190548B (en) 1986-09-29

Similar Documents

Publication Publication Date Title
MY102038A (en) 4-substituted androstendione derivatives and process for their preparation
IE790088L (en) Thienohydantoin derivatives
AU543916B2 (en) Spiro(imidazolidine-indolines) and spiro (imidazolidine- azaindolines)
IE851155L (en) Benzo-(pyrano and thiopyrano)-pyridines
IE43660L (en) Spiro [isobenzofuran-1,4'-piperidine] derivatives
ES8400116A1 (es) "un procedimiento por analogia para la preparacion de derivados de espiro-oxindol-oxazolidindiona".
ES8103090A1 (es) Un procedimiento para la preparacion de espiro-quinolilludantoinas, utiles como inhibidores de la aldosa-reductasa para el tratamiento de las complicaciones cronicas de la diabetes
MY103765A (en) Azolidinedione derivatives
ES8607312A1 (es) Un procedimiento para la preparacion de un compuesto seleccionado entre el grupo formado por los isomeros dextrogiros de espiro-hidantoinas asimetricas
IE800672L (en) Spiro-quinolone hydantoins
AU2773184A (en) Spiro(imidazolidine-4,3:-indoline) derivatives
MY101896A (en) New tetracyclic indole derivatives
HUT44769A (en) Process for producing spiro/benzofuran-2(3h),1'-cycloheptane/ derivatives and pharmaceutical preparations comprising these compounds
AU566869B2 (en) Spiro (imidazolidine-4,3'-indoline) 2,2',5-triones
FI832959A (fi) Spiro/2h-1,4-benzodiazepin-3(5h)4'-piperidin och 3'-pyrrolidin/foereningar, foerfarande foer deras framstaellning och deras anvaendning som laekemedel